| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxart, Inc. | Director | Common Stock | 124,125 | $50,518 | $0.4070 | 17 Nov 2025 | Direct |
| Vaxart, Inc. | Director | Stock Option (right to buy) | 95,400 | 13 Jun 2025 | Direct | ||
| BIODELIVERY SCIENCES INTERNATIONAL INC | Director | Common Stock | 0 | $1.80 | 22 Mar 2022 | Direct | |
| BIODELIVERY SCIENCES INTERNATIONAL INC | Director | Restricted Stock Units | 0 | 22 Mar 2022 | Direct | ||
| BIODELIVERY SCIENCES INTERNATIONAL INC | Director | Stock Options (right to buy) | 0 | $3.66 | 22 Mar 2022 | Direct | |
| SYKES ENTERPRISES INC | Director | Common Stock | 0 | $41.62 | 27 Aug 2021 | Direct |